Your browser doesn't support javascript.
loading
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
Beier, R; Schulz, A; Hönig, M; Eyrich, M; Schlegel, P-G; Holter, W; Stachel, K D; Ehlert, K; Greil, J; Nürnberger, W; Wössmann, W; Bader, P; Urban, C; Müller, I; Suttorp, M; Sauer, M; Gruhn, B; Meisel, R; Zimmermann, M; Sykora, K-W.
Afiliación
  • Beier R; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Bone Marrow Transplant ; 48(4): 491-501, 2013 Apr.
Article en En | MEDLINE | ID: mdl-23085832
We report the long-term follow-up of children transplanted with Treosulfan (TREO)-based conditioning in Germany and Austria. Nine centres reported a total of 109 transplantations. Patients were stratified according to the paediatric TRM risk score derived from the paediatric BMT registry (PRST) and compared with the historical transplant population of this registry. Underlying diseases were malignancies, immunodeficiencies, and haematologic and metabolic disorders. TREO total dose ranged from 21-42 g/m(2). Additional conditioning drugs included fludarabine, thiotepa, melphalan, CY and/or TBI. EFS at 3 years for non-malignant and malignant diseases was 88% and 49%, respectively. Leukaemia patients in remission had a survival of 51% at 3 years; nonremission patients relapsed and died within 18 months. TRM and OS in the low-risk groups 0 and 1 were similar to PRST controls. TRM in the high-risk groups 2 and 3 was markedly lower (9% vs 28% and 13% vs 53%, respectively) than in the PRST group, but OS was similar. In conclusion, TREO-based conditioning regimens in children resulted in excellent engraftment and long-term survival in nonmalignant disease. In high-risk malignancy, low acute toxicity was followed by low TRM but it did not translate into increased survival.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Busulfano / Sistema de Registros / Trasplante de Médula Ósea / Antineoplásicos Alquilantes / Acondicionamiento Pretrasplante / Agonistas Mieloablativos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2013 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Busulfano / Sistema de Registros / Trasplante de Médula Ósea / Antineoplásicos Alquilantes / Acondicionamiento Pretrasplante / Agonistas Mieloablativos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2013 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido